Susha Cheriyedath

Susha Cheriyedath

Feature Writer

B.Sc Chemistry, M.Sc. Biochemistry

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

See more

Passionate about health and nutrition, Susha is interested in various diet types, such as veganism, and their impact on the body and metabolism. She remains dedicated to staying current with the latest developments in the medical and health science fields. In her leisure time, she engages in gardening, cooking/baking, and sketching/painting. When not immersed in work, she can often be found tending to her garden (weather permitting) or engrossed in her sketching and painting projects.

See less

Articles from Susha

CASdetec: new CRISPR-based SARS-CoV-2 detection platform detects nucleic acids with high sensitivity and specificity

CASdetec: new CRISPR-based SARS-CoV-2 detection platform detects nucleic acids with high sensitivity and specificity

Decreasing activity of ZMPSTE24 protease with age and comorbidities may make elderly COVID-19 patients vulnerable

Decreasing activity of ZMPSTE24 protease with age and comorbidities may make elderly COVID-19 patients vulnerable

SARS-CoV-2 mutations strengthen RBD-ACE2 binding, making the virus more infectious

SARS-CoV-2 mutations strengthen RBD-ACE2 binding, making the virus more infectious

Australian discovery could speed up SARS-CoV-2 vaccine development

Australian discovery could speed up SARS-CoV-2 vaccine development

North America has 87% of all unique SARS-CoV-2 S protein variants in the NCBI database among six continents

North America has 87% of all unique SARS-CoV-2 S protein variants in the NCBI database among six continents

Swiss study suggests very low prevalence of long COVID in pediatric population

Swiss study suggests very low prevalence of long COVID in pediatric population

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Antithrombotic endothelial dysfunction is prevented by Tie2 activation in severe COVID-19

Antithrombotic endothelial dysfunction is prevented by Tie2 activation in severe COVID-19

Working conditions and non-workplace factors affect COVID-19 mortality in England

Working conditions and non-workplace factors affect COVID-19 mortality in England

Human monoclonal antibodies neutralize SARS-CoV-2 in an Fc-independent manner

Human monoclonal antibodies neutralize SARS-CoV-2 in an Fc-independent manner

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.